Today on the AI Daily Brief, the significance of codex coming to chat GPT mobile, the difference

between consumer and work AI, and what to expect from Google's I.O. event next week. Before that,

in the headlines, a heck of a first day for Cerebrus on Wall Street. The AI Daily Brief is a daily

podcast and video about the most important news and discussions in AI. All right, friends, quick announcements before we dive in. First of all, thank you to today's sponsors, KPMG, Granola, Bolton, and Section. To get an ad-free version of the show, go to patreon.com slash AI Daily Brief, or you can subscribe in Apple Podcasts. To learn more about sponsoring the show, send us a note at sponsors at AIDailybrief.aI.i. While you are on A.iDailybrief.aI., check out our careers page.

I am hiring a full-time growth engineer that is someone who is engineering growth, not a

developer by training necessarily, although you will be building lots. But it is a very cool

way to be a part of this ecosystem. And one final

note, Enterprise Claw Cohort 3 is currently enrolling. You can find out about that either from our website

or at EnterpriseClaw.a.i. Today we kick off with a follow-up of a story that we have been watching

this week, which is the public market debut of Cerebrus. TLDR, the company, delivered a massive

first day of trading, kicking off a potentially significant IPO season for AI companies.

Now, heading into the big day, Cerebrus had upsized their share offering, raised their price,

and still, after all of that, ended up pricing the sale above their guided range.

Red Hot demand during

the private road show flowed through into public markets on Thursday, with the opening

trade seeing the stock double in price before settling into a 68% gain at the end of trading.

Cerevers began the day as a $40 billion company, touched $100 billion for a minute, and now

has a market cap of $66 billion. Now, predictably for a frothy IPO, and I think that is a certainly reasonable frame, the launch brought out a fair number of contrarians on the stock. CNBC's Jim Kramer warned his audience to tread carefully, arguing that the price had detached from fundamentals. While there might be a situation in the future where I can recommend Cerevers, he said, I just can't even come close to justifying the valuation up here, given how much it's already run right out of the gate. For now, I say, keep your bat on your shoulder and hope the stock gives you a giant pullback because at these levels it's too rich for me. Meanwhile, General Intelligence's Andrew Pickenlli was one of many declaring, quote, the Cerebris IPO may be the top. CNBC reported that there were

45 buyers for every seller of the stock, with Paki McCormick tongue-in-cheek arguing that the same

is true for Cerebris' product posting, once again, you people don't understand infinites.

If inference demand is infinite, Cerebris at $400 is ridiculously cheap. Infinity times their

inference market share equals infinity.

...